Mopidamol, CAS 13665-88-8

Product Description: Mopidamol (RA 233), a derivative of Dipyridamole (HY-B0312), is a phosphodiesterase inhibitor. Mopidamol can be used for non-small cell lung cancer (N-SCLC) research[1][2].

Applications: Cancer-programmed cell death

Formula: C19H31N7O4

References: [1]Eliasson R, Bygdeman S. Effect of dipyridamole and two pyrimido-pyrimidine derivatives on the kinetics of human platelet aggregation and on platelet adhesiveness. Scand J Clin Lab Invest. 1969 Sep;24(2):145-51./[2]Zacharski LR, et al. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188. J Natl Cancer Inst. 1988 Mar 16;80(2):90-7.

CAS Number: 13665-88-8

Molecular Weight: 421.49

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Phosphodiesterase (PDE)

• Artikelnummer: MEXHY-106618-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-106618-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK